145 related articles for article (PubMed ID: 37448523)
1. The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis.
Kuipers S; Godart J; Corbeau A; Sharfo AW; Breedveld S; Mens JW; de Boer S; Nout R; Hoogeman M
Front Oncol; 2023; 13():1138433. PubMed ID: 37448523
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer.
Kuipers SC; Godart J; Corbeau A; Breedveld S; Mens JWM; de Boer SM; Nout RA; Hoogeman MS
Radiother Oncol; 2024 Jun; 195():110222. PubMed ID: 38471634
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
4. Beam configuration selection for robust intensity-modulated proton therapy in cervical cancer using Pareto front comparison.
van de Schoot AJ; Visser J; van Kesteren Z; Janssen TM; Rasch CR; Bel A
Phys Med Biol; 2016 Feb; 61(4):1780-94. PubMed ID: 26854384
[TBL] [Abstract][Full Text] [Related]
5. A Dosimetric Analysis of Modified Volumetric Modulated Arc Therapy for Bone Marrow Sparing Radiotherapy in Cervical Cancer-An alternative Approach to Conventional VMAT.
Palani D; Govindaraj K; Sampathrajan S; Karunagaran L; Ganesh KM
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4323-4332. PubMed ID: 36580016
[TBL] [Abstract][Full Text] [Related]
6. Extended-field bone marrow sparing radiotherapy for primary chemoradiotherapy in cervical cancer patients with para-aortic lymphadenopathy: Volumetric-modulated arc therapy versus helical tomotherapy.
Chen JL; Wang MC; Huang YS; Huang CY; Pan CK; Hsu CY; Lan KH; Kuo SH
J Xray Sci Technol; 2020; 28(1):111-124. PubMed ID: 31904003
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.
Lujan AE; Mundt AJ; Yamada SD; Rotmensch J; Roeske JC
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):516-21. PubMed ID: 12957265
[TBL] [Abstract][Full Text] [Related]
8. Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?
Yu DY; Bai YL; Feng Y; Wang L; Yun WK; Li X; Song JY; Yang SS; Zhang YY
Front Oncol; 2020; 10():554241. PubMed ID: 33392067
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Multi-Criteria Optimization-based Trade-Off exploration in combination with RapidPlan for head & neck radiotherapy planning.
Miguel-Chumacero E; Currie G; Johnston A; Currie S
Radiat Oncol; 2018 Nov; 13(1):229. PubMed ID: 30470254
[TBL] [Abstract][Full Text] [Related]
10. Complementing Prostate SBRT VMAT With a Two-Beam Non-Coplanar IMRT Class Solution to Enhance Rectum and Bladder Sparing With Minimum Increase in Treatment Time.
Sharfo AWM; Rossi L; Dirkx MLP; Breedveld S; Aluwini S; Heijmen BJM
Front Oncol; 2021; 11():620978. PubMed ID: 33816253
[TBL] [Abstract][Full Text] [Related]
11. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.
Ciabatti S; Ntreta M; Buwenge M; Gaudiano C; Sessagesimi E; Romani F; Angelini AL; Cammelli S; Macchia G; Deodato F; Zamagni A; Golfieri R; Morganti AG; Cilla S
Med Dosim; 2019 Winter; 44(4):356-364. PubMed ID: 30955990
[TBL] [Abstract][Full Text] [Related]
12. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
13. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
14. Pareto fronts in clinical practice for pinnacle.
Janssen T; van Kesteren Z; Franssen G; Damen E; van Vliet C
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):873-80. PubMed ID: 22901383
[TBL] [Abstract][Full Text] [Related]
15. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric evaluation of bone marrow sparing in proton radiotherapy for cervical cancer guided by MR functional imaging.
Qin X; Gong G; Wang L; Su Y; Yin Y
Radiat Oncol; 2022 Dec; 17(1):207. PubMed ID: 36517839
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic.
Stevens MJ; Ko F; Martland J; Brown R; Bell L; Atyeo J; Yim J
Radiat Oncol; 2023 Mar; 18(1):54. PubMed ID: 36941643
[TBL] [Abstract][Full Text] [Related]
18. RapidPlan development of VMAT plans for cervical cancer patients in low- and middle-income countries.
Tinoco M; Waga E; Tran K; Vo H; Baker J; Hunter R; Peterson C; Taku N; Court L
Med Dosim; 2020 Summer; 45(2):172-178. PubMed ID: 31740042
[TBL] [Abstract][Full Text] [Related]
19. Gamma Knife and volumetric modulated arc therapy stereotactic radiosurgery plan quality and OAR sparing comparison for pituitary adenomas and vestibular schwannomas.
Balik S; Chao S; Neyman G
J Radiosurg SBRT; 2018; 5(3):237-247. PubMed ID: 29988324
[TBL] [Abstract][Full Text] [Related]
20. Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.
Arnesen MR; Rekstad BL; Stokke C; Bruheim K; Løndalen AM; Hellebust TP; Malinen E
Radiat Oncol; 2016 Mar; 11():39. PubMed ID: 26968827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
